Present role of prophylactic cranial irradiation;Place actuelle de l'irradiation prophylactique cérébrale

Bulletin du Cancer

Volumn 100, Issue 1, 2013, Pages 35-43

  Péchoux, Cécile Le ^a   Mohkles, Hweej Al ^a   Dhermain, Frédéric ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Lung cancer; Neurotoxicity; Non small cell lung cancer; Prophylactic cranial irradiation; Radiotherapy; Small cell cancer

Indexed keywords

BRAIN METASTASIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; HUMAN; LOCAL THERAPY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PROPHYLACTIC CRANIAL IRRADIATION; PROPHYLAXIS; RADIATION DOSE FRACTIONATION; REVIEW; SKULL IRRADIATION;

EID: 84875168672     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2012.1678     Document Type: Article

References (57)

1. Blanchard P, Le Péchoux C. Prophylactic cranial irradiation in lung cancer. Curr Opin Oncol 2010; 22: 94-101.
2. Planchard D, Le Péchoux C. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment. Eur J Cancer 2011; 47 (Suppl. 3):S272-83.
3. Komaki R. Prophylactic cranial irradiation for small cell carcinoma of the lung. Cancer Treat Symptom 1985; 2: 35-9.
4. Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 1995;87: 183-90.
5. Kristensen CA, Kristjansen PEG, Hansen HH. Systemic chemotherapy of brain metastases from small cell lung cancer. A review. J Clin Oncol 1992;10:1498-502.
6. Reveiz L, Rueda JR, Cardona AF. Chemotherapy for brain metastases from small cell lung cancer. Cochrane Database Syst Rev 2012; issue 6: Art No: CD007464. doi: 10.1002/14651858.CD007464.pub2.
7. Aroney RS, Aisner J, Wesley MN, et al. Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat 1983;Rep. 67:675-82.
8. Beiler DD, Kane RC, Bernath AM, Cashdollar MR. Low dose elective brain irradiation in small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1979; 5: 941-5.
9. Cox JD, Petrovich Z, Paig C, Stanley K. Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung. Preliminary report of a cooperative trial. Cancer 1978;42:1135-40.
10. Eagan RT, Frytak S, Lee RE, Creagan ET, Ingle JN, Nichols WC. A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small cell lung cancer. Cancer Clin Trials 1981; 4: 261-6.
11. Hansen HH, Dombernowsky P, Hirsch FR, Hansen M, Rygard J. Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy. Cancer 1980; 46:279-84.
12. Jackson Jr. DV, Richards F, Cooper MR, et al. Prophylactic cranial irradiation in small cell carcinoma of the lung. A randomized study. JAMA 1983;237:2730-3.
13. Maurer LH, Tulloh M, Weiss RB, et al. A randomized combined modality trial in small cell carcinoma of the lung/comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 1980; 45:30-9.
14. Niiranen A, Holsti P, Salmo M. Treatment of small cell lung cancer. Two-drug vs four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiation. Acta Oncol 1989; 28:501-5.
15. Seydel HG, Creech R, Pagano M, et al. Prophylactic versus no brain irradiation in regional small cell lung carcinoma. Am J Clin Oncol 1985; 8: 218-23.
16. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer 1997;33:1752-8.
17. Laplanche A, Monnet I, Santos-Miranda JA, et al. Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Lung Cancer 1998; 21: 193-201.
18. Ohonoshi T, Ueoka H, Kawahara S, et al. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: a long-term follow-up result. Lung Cancer 1994; 10: 47-54.
19. Wagner HJ, Kim K, Turrisi A. A randomized phase III study of prophylactic cranial irradiation vs observation in patients with small cell lung cancer achieving a complete response: final report of an incomplete trial by the ECOG and RTOG. Proc Am Soc Clin Oncol 1996; 15:376.
20. Aupérin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission: a meta-analysis of individual data from 987 patients. N Engl J Med 1999; 341: 476-84.
21. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327: 1618-24.
22. Lee JS, Umsawasdi T, Barkley Jr. HT, et al. Timing of elective brain irradiation: a critical factor for brain metastasis-free survival in small cell lung cancer. Int J Radiat Oncol Biol Phys 1987; 13: 697-704.
23. Perez CA, Krauss S, Bartolucci AA, et al. Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung. Cancer 1981;47:2407-13.
24. Wolfson AH, Bains Y, Lu J, et al. Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy. Report of a single institutional phase II trial. Am J Clin Oncol 2001;24: 290-5.
25. Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81: 77-84.
26. Le Péchoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomized clinical trial. Lancet Oncol 2009;10: 467-74.
27. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357: 664-72.
28. Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 2009;27: 78-84.
29. Patel S, Macdonald OK, Suntharalingam M. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Cancer 2009;115: 842-50.
30. Carolan H, Suna AY, Bezjak A, et al. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection? Lung Cancer 2005; 49:109-15.
31. Cox JD, Stanley K, Petrovich Z, Paig C, Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981; 245: 469-72.
32. Umsawasdi T, Valdivieso M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 1984; 2: 253-9.
33. Russell AH, Pajak TE, Selim HM, et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991;21: 637-43.
34. Gore EM, Bae K, Wong SJ, et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of Radiation Therapy Oncology Group study RTOG 0214. J Clin Oncol 2011;29: 272-8.
35. Stuschke M, Eberhardt W, Pottgen C, et al. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multi-modality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 1999;17: 2700-9.
36. Pöttgen C, Eberhardt W, Grannass A, et al. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multi-center randomized trial. J Clin Oncol 2007;25:4987-92.
37. Craig JB, Jackson DV, Moody D, et al. Prospective evaluation of changes in computerized cranial tomography (CCT) in patients with small cell carcinoma (SCLC) treated with chemotherapy and cranial irradiation. J Clin Oncol 1984; 2: 1151-6.
38. Johnson BE, Patronas N, Hayes W, et al. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small cell lung cancer: further follow-up to 6-to 13-year survivors. J Clin Oncol 1990; 8: 48-56.
39. Laukkanen E, Klonoff H, Allan B, Graeb D, Murray N. The role of prophylactic brain irradiation in limited stage small cell lung cancer: clinical, neuropsychologic, and CT sequelae. Int J Radiat Oncol Biol Phys 1988;14: 1109-18.
40. Lishner M, Feld R, Payne DG, et al. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience. J Clin Oncol 1990; 8: 215-21.
41. Ahles TA, Silberfarb PM, Herndon J, et al. Psychologic and neu-ropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. J Clin Oncol 1998;16:1954-60.
42. Van Oosterhout AGM, van dePol M, ten Velde GPM, Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 1996; 77: 1434-41.
43. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-82.
44. Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R. Neurocognitive function in patients with small cell lung cancer: effect of prophylactic cranial irradiation. Cancer 2008; 112: 589-95.
45. Sun A, Bae K, Gore EM, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011; 29: 279-86.
46. Le Péchoux C, Laplanche A, Faivre-Finn C, et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI 99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol 2011; 22:1154-63.
47. Erlington GM, Murray NM, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991; 54: 764-7.
48. Hill R. Residual effects of cigarette smoking on cognitive performance in normal aging. Psychol Aging 1989; 4: 251-4.
49. Lecacheux M, Karila L, Aubin HJ, et al. Altérations cognitives liées au tabac. Presse Med 2009;38:1241-52.
50. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-72.
51. Pelletier EM, Shim B, Goodman S, Amonkar MM. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 2008; 108: 297-305.
52. Gabos Z, Sinha R, Hanson J, et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 2006;24:5658-63.
53. Park YH, Park MJ, Ji SH, et al. Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer 2009;100:894-900.
54. Niwińska A, Tacikowska M, Murawska M. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. Int J Radiat Oncol Biol Phys 2010;77: 1134-9.
55. Le Tourneau C. Stratégies de prévention des métastases céré-brales dans les cancers du sein HER2+. Bull Cancer 2011;98:445-9.
56. Huang F, Alrefae M, Langleben A, Roberge D. Prophylactic cranial irradiation in advanced breast cancer: a case for caution. Int J Radiat Oncol Biol Phys 2009; 73: 752-8.
57. Likhacheva A, Pinnix CC, Parikh NR, et al. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2012 (http://dx.doi. org/10.1016/j.ijrobp.2012.05.047).